Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
Add more filters











Database
Language
Publication year range
1.
J Bacteriol ; 190(8): 2739-58, 2008 Apr.
Article in English | MEDLINE | ID: mdl-18203836

ABSTRACT

Patients suffering from cystic fibrosis (CF) commonly harbor the important pathogen Pseudomonas aeruginosa in their airways. During chronic late-stage CF, P. aeruginosa is known to grow under reduced oxygen tension and is even capable of respiring anaerobically within the thickened airway mucus, at a pH of approximately 6.5. Therefore, proteins involved in anaerobic metabolism represent potentially important targets for therapeutic intervention. In this study, the clinically relevant "anaerobiome" or "proteogenome" of P. aeruginosa was assessed. First, two different proteomic approaches were used to identify proteins differentially expressed under anaerobic versus aerobic conditions. Microarray studies were also performed, and in general, the anaerobic transcriptome was in agreement with the proteomic results. However, we found that a major portion of the most upregulated genes in the presence of NO(3)(-) and NO(2)(-) are those encoding Pf1 bacteriophage. With anaerobic NO(2)(-), the most downregulated genes are those involved postglycolytically and include many tricarboxylic acid cycle genes and those involved in the electron transport chain, especially those encoding the NADH dehydrogenase I complex. Finally, a signature-tagged mutagenesis library of P. aeruginosa was constructed to further screen genes required for both NO(3)(-) and NO(2)(-) respiration. In addition to genes anticipated to play important roles in the anaerobiome (anr, dnr, nar, nir, and nuo), the cysG and dksA genes were found to be required for both anaerobic NO(3)(-) and NO(2)(-) respiration. This study represents a major step in unraveling the molecular machinery involved in anaerobic NO(3)(-) and NO(2)(-) respiration and offers clues as to how we might disrupt such pathways in P. aeruginosa to limit the growth of this important CF pathogen when it is either limited or completely restricted in its oxygen supply.


Subject(s)
Cystic Fibrosis/microbiology , Gene Expression Profiling , Gene Expression Regulation, Bacterial , Proteome/analysis , Pseudomonas aeruginosa/physiology , Anaerobiosis , Bacteriophage Pf1/genetics , DNA Transposable Elements , Electrophoresis, Gel, Two-Dimensional , Humans , Hydrogen-Ion Concentration , Mutagenesis, Insertional , Nitrates/metabolism , Nitrites/metabolism , Oligonucleotide Array Sequence Analysis , Pseudomonas aeruginosa/chemistry , Pseudomonas aeruginosa/genetics , Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization , Viral Proteins/biosynthesis
2.
J Bacteriol ; 188(21): 7335-43, 2006 Nov.
Article in English | MEDLINE | ID: mdl-17050921

ABSTRACT

Multiple environmental cues have been shown to trigger biofilm detachment, the transition from surface-attached, highly organized communities known as biofilms to the motile lifestyle. The goal of this study was to identify a gene product involved in sensing environmental cues that trigger biofilm dispersion in Pseudomonas aeruginosa. To do so, we focused on novel putative chemotaxis transducer proteins that could potentially be involved in environmental sensing. We identified a locus encoding such a protein that played a role in detachment, as indicated by the observation that an isogenic mutant biofilm could not disperse in response to a variety of environmental cues. The locus was termed bdlA for biofilm dispersion locus. The BdlA protein harbors an MCP (methyl-accepting chemotaxis protein) domain and two PAS (Per-Arnt-Sint) domains that have been shown to be essential for responding to environmental signals in other proteins. The dispersion-deficient phenotype of the bdlA mutant was confirmed by treatment with the biocide H(2)O(2) and by microscopic observations. The dispersion response was independent of motility. bdlA mutant biofilms were found to have increased adherent properties and increased intracellular levels of cyclic di-GMP (c-di-GMP). Our findings suggest that BdlA may be a link between sensing environmental cues, c-di-GMP levels, and detachment. Based on our findings, a possible involvement of BdlA in a signaling cascade resulting in biofilm dispersion is discussed.


Subject(s)
Adaptation, Physiological , Bacterial Proteins/physiology , Biofilms , Chemotaxis/genetics , Pseudomonas aeruginosa/physiology , Signal Transduction , Anti-Bacterial Agents/pharmacology , Bacterial Adhesion/genetics , Bacterial Proteins/genetics , Cytoplasm/chemistry , Gene Deletion , Guanine Nucleotides/analysis , Hydrogen Peroxide/pharmacology , Microscopy , Models, Biological , Movement , Mutagenesis, Insertional , Protein Structure, Tertiary , Pseudomonas aeruginosa/genetics
3.
J Bacteriol ; 188(21): 7344-53, 2006 Nov.
Article in English | MEDLINE | ID: mdl-17050922

ABSTRACT

Bacterial biofilms at times undergo regulated and coordinated dispersal events where sessile biofilm cells convert to free-swimming, planktonic bacteria. In the opportunistic pathogen Pseudomonas aeruginosa, we previously observed that dispersal occurs concurrently with three interrelated processes within mature biofilms: (i) production of oxidative or nitrosative stress-inducing molecules inside biofilm structures, (ii) bacteriophage induction, and (iii) cell lysis. Here we examine whether specific reactive oxygen or nitrogen intermediates play a role in cell dispersal from P. aeruginosa biofilms. We demonstrate the involvement of anaerobic respiration processes in P. aeruginosa biofilm dispersal and show that nitric oxide (NO), used widely as a signaling molecule in biological systems, causes dispersal of P. aeruginosa biofilm bacteria. Dispersal was induced with low, sublethal concentrations (25 to 500 nM) of the NO donor sodium nitroprusside (SNP). Moreover, a P. aeruginosa mutant lacking the only enzyme capable of generating metabolic NO through anaerobic respiration (nitrite reductase, DeltanirS) did not disperse, whereas a NO reductase mutant (DeltanorCB) exhibited greatly enhanced dispersal. Strategies to induce biofilm dispersal are of interest due to their potential to prevent biofilms and biofilm-related infections. We observed that exposure to SNP (500 nM) greatly enhanced the efficacy of antimicrobial compounds (tobramycin, hydrogen peroxide, and sodium dodecyl sulfate) in the removal of established P. aeruginosa biofilms from a glass surface. Combined exposure to both NO and antimicrobial agents may therefore offer a novel strategy to control preestablished, persistent P. aeruginosa biofilms and biofilm-related infections.


Subject(s)
Biofilms , Nitric Oxide/physiology , Pseudomonas aeruginosa/physiology , Adaptation, Physiological , Anaerobiosis , Anti-Bacterial Agents/pharmacology , Biofilms/drug effects , Colony Count, Microbial , Drug Synergism , Gene Deletion , Gene Expression Regulation, Bacterial , Hydrogen Peroxide/pharmacology , Microscopy, Fluorescence , Movement , Nitric Oxide/metabolism , Nitric Oxide Donors/pharmacology , Nitrite Reductases/genetics , Nitroprusside/pharmacology , Oxidoreductases/genetics , Pseudomonas aeruginosa/drug effects , Sodium Dodecyl Sulfate/pharmacology , Tobramycin/pharmacology
4.
J Clin Invest ; 116(2): 436-46, 2006 Feb.
Article in English | MEDLINE | ID: mdl-16440061

ABSTRACT

Mucoid, mucA mutant Pseudomonas aeruginosa cause chronic lung infections in cystic fibrosis (CF) patients and are refractory to phagocytosis and antibiotics. Here we show that mucoid bacteria perish during anaerobic exposure to 15 mM nitrite (NO2) at pH 6.5, which mimics CF airway mucus. Killing required a pH lower than 7, implicating formation of nitrous acid (HNO2) and NO, that adds NO equivalents to cellular molecules. Eighty-seven percent of CF isolates possessed mucA mutations and were killed by HNO2 (3-log reduction in 4 days). Furthermore, antibiotic-resistant strains determined were also equally sensitive to HNO2. More importantly, HNO2 killed mucoid bacteria (a) in anaerobic biofilms; (b) in vitro in ultrasupernatants of airway secretions derived from explanted CF patient lungs; and (c) in mouse lungs in vivo in a pH-dependent fashion, with no organisms remaining after daily exposure to HNO2 for 16 days. HNO2 at these levels of acidity and NO2 also had no adverse effects on cultured human airway epithelia in vitro. In summary, selective killing by HNO2 may provide novel insights into the important clinical goal of eradicating mucoid P. aeruginosa from the CF airways.


Subject(s)
Cystic Fibrosis/metabolism , Drug Resistance, Bacterial , Nitrites/metabolism , Pseudomonas aeruginosa/metabolism , Anaerobiosis , Animals , Bacterial Proteins/genetics , Bacterial Proteins/metabolism , Biofilms , Cells, Cultured , Child , Child, Preschool , Cystic Fibrosis/microbiology , Epithelial Cells/cytology , Humans , Hydrogen-Ion Concentration , Infant , Mice , Microbial Sensitivity Tests , Mucus/chemistry , Pseudomonas Infections , Pseudomonas aeruginosa/genetics , Respiratory Mucosa/cytology , Sputum/chemistry , Sputum/microbiology
5.
J Bacteriol ; 187(14): 4853-64, 2005 Jul.
Article in English | MEDLINE | ID: mdl-15995200

ABSTRACT

The impact of arsenite [As(III)] on several levels of cellular metabolism and gene regulation was examined in Pseudomonas aeruginosa. P. aeruginosa isogenic mutants devoid of antioxidant enzymes or defective in various metabolic pathways, DNA repair systems, metal storage proteins, global regulators, or quorum sensing circuitry were examined for their sensitivity to As(III). Mutants lacking the As(III) translocator (ArsB), superoxide dismutase (SOD), catabolite repression control protein (Crc), or glutathione reductase (Gor) were more sensitive to As(III) than wild-type bacteria. The MICs of As(III) under aerobic conditions were 0.2, 0.3, 0.8, and 1.9 mM for arsB, sodA sodB, crc, and gor mutants, respectively, and were 1.5- to 13-fold less than the MIC for the wild-type strain. A two-dimensional gel/matrix-assisted laser desorption ionization-time of flight analysis of As(III)-treated wild-type bacteria showed significantly (>40-fold) increased levels of a heat shock protein (IbpA) and a putative allo-threonine aldolase (GlyI). Smaller increases (up to 3.1-fold) in expression were observed for acetyl-coenzyme A acetyltransferase (AtoB), a probable aldehyde dehydrogenase (KauB), ribosomal protein L25 (RplY), and the probable DNA-binding stress protein (PA0962). In contrast, decreased levels of a heme oxygenase (HemO/PigA) were found upon As(III) treatment. Isogenic mutants were successfully constructed for six of the eight genes encoding the aforementioned proteins. When treated with sublethal concentrations of As(III), each mutant revealed a marginal to significant lag period prior to resumption of apparent normal growth compared to that observed in the wild-type strain. Our results suggest that As(III) exposure results in an oxidative stress-like response in P. aeruginosa, although activities of classic oxidative stress enzymes are not increased. Instead, relief from As(III)-based oxidative stress is accomplished from the collective activities of ArsB, glutathione reductase, and the global regulator Crc. SOD appears to be involved, but its function may be in the protection of superoxide-sensitive sulfhydryl groups.


Subject(s)
Arsenites/pharmacology , Pseudomonas aeruginosa/drug effects , Pseudomonas aeruginosa/genetics , Bacterial Proteins/genetics , Bacterial Proteins/isolation & purification , Drug Resistance, Bacterial , Genotype , Glutathione Reductase/genetics , Glutathione Reductase/metabolism , Microbial Sensitivity Tests , Models, Biological , Mutagenesis , Pseudomonas aeruginosa/classification , Pseudomonas aeruginosa/enzymology
6.
Infect Immun ; 72(9): 5433-8, 2004 Sep.
Article in English | MEDLINE | ID: mdl-15322041

ABSTRACT

The transcriptional profile of Pseudomonas aeruginosa after interactions with primary normal human airway epithelial cells was determined using Affymetrix GeneChip technology. Gene expression profiles indicated that various genes involved in phosphate acquisition and iron scavenging were differentially regulated.


Subject(s)
Bacterial Proteins/metabolism , Epithelial Cells/microbiology , Gene Expression Regulation, Bacterial , Oligonucleotide Array Sequence Analysis/methods , Pseudomonas aeruginosa/growth & development , Respiratory System/microbiology , Transcription, Genetic , Bacterial Proteins/genetics , Cells, Cultured , Gene Expression Profiling , Humans , Iron/metabolism , Phosphates/metabolism , Pseudomonas aeruginosa/metabolism , Respiratory System/cytology
7.
Adv Drug Deliv Rev ; 54(11): 1425-43, 2002 Dec 05.
Article in English | MEDLINE | ID: mdl-12458153

ABSTRACT

Recent evidence indicates that Pseudomonas aeruginosa residing as biofilms in airway mucus of cystic fibrosis (CF) patients is undergoing anaerobic metabolism, a form of growth requiring gene products that are not utilized during aerobic growth. The outer membrane protein, OprF, and the rhl quorum sensing circuit are two previously unrecognized cellular factors that are required for optimal anaerobic biofilm viability. Without OprF, bacteria grow extremely poorly because they lack nitrite reductase activity while lacking rhlR or rhlI forces bacteria to undergo metabolic suicide by overproduction of nitric oxide. Furthermore, anaerobic growth favors maintenance of the mucoid, alginate-overproducing phenotype. Thus, with increasing age of CF patients, mucoid populations predominate, indicating that anaerobic bacteria reside in the inspissated airway mucus. Because many frontline antibiotics used in the treatment of CF airway disease are either ineffective or show reduced efficacy during anaerobic conditions, we propose development of new drugs to combat anaerobic metabolism by P. aeruginosa for more effective treatment of chronic CF lung infections.


Subject(s)
Anti-Bacterial Agents/therapeutic use , Biofilms/growth & development , Cystic Fibrosis/microbiology , Pseudomonas Infections/drug therapy , Pseudomonas aeruginosa/metabolism , Respiratory System/microbiology , Alginates/metabolism , Anaerobiosis , Bacterial Proteins/genetics , Bacterial Proteins/metabolism , Chronic Disease , Glucuronic Acid , Hexuronic Acids , Humans , Ligases , Mucus/microbiology , Nitric Oxide/metabolism , Porins/metabolism , Pseudomonas Infections/microbiology , Pseudomonas aeruginosa/drug effects , Pseudomonas aeruginosa/physiology , Transcription Factors/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL